Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia.

ABSTRACT:

SUBMITTER: Topp MS 

PROVIDER: S-EPMC5808068 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature